AI Article Synopsis
- * A total of 13 different mutations were identified, with three Mediterranean mutations accounting for 54% of the tested chromosomes and six additional Mediterranean alleles comprising 24%.
- * Additionally, some mutations were linked to Arabian, Southeast Asian/Indian, Iranian/Egyptian, or Black populations, while four beta-thalassemia mutations remained unidentified in the study.
Article Abstract
We have studied the beta-thalassemia mutations in 91 chromosomes of 43 patients with beta-thalassemia major and five with Hb S-beta-thalassemia, aged 6 months to 24 years. Many are blood transfusion-dependent and are being treated at the major hospital, the Princess Basma Hospital, in Irbid, Jordan. As many as 13 different mutations have been identified; three Mediterranean mutations [IVS-I-110 (G-->A), IVS-II-I (G-->A), and IVS-II-745 (C-->G)] were present in 54% of the chromosomes tested, while six other Mediterranean alleles were found in 24% of the chromosomes, for a total of 78% of Mediterranean origin. Sixteen chromosomes carried mutations which were observed in Arabian, Southeast Asian/Indian, and Iranian/Egyptian or Black populations; four beta-thalassemia mutations remained unidentified.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/03630269408996198 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
False HbA value due to a rare variant of hemoglobin Petie Salpetriere coinherited with alpha thalassemia.
Adv Lab Med
December 2024
Department of Laboratory Service, Área de Gestión Sanitaria Norte de Huelva, Hospital de Riotinto, Minas de Riotinto, Huelva, Spain.
Objectives: To describe a variant hemoglobin that interferes with HbA analysis by cation exchange HPLC.
Case Presentation: A 78 years-old Spanish male patient visited the Internal Medicine Clinic for a routine check-up, with HbA included to screen for diabetes. He had suffered hypertension and dyslipidemia, and the patient had no previous symptoms suggestive of diabetes such as hyperglycemia, weight loss, polydipsia, polyuria or tiredness.
Accumulation of free α-globin is a critical factor in the pathogenesis of β-thalassemia. Autophagy plays a crucial role in clearing toxic free α-globin, thereby reducing disease severity. However, the impact of natural mutations in autophagy-related genes (ATGs) on the phenotypic variability of β-thalassemia remains unclear.
View Article and Find Full Text PDFThe value of Mentzer index in the diagnosis of children thalassemia minor.
Hematology
December 2024
Department of Laboratory Medicine, Shenzhen Pediatrics Institute of Shantou University Medical College, Shenzhen, People's Republic of China.
Objective: To explore the effect of the Mentzer Index (MI) in screening for children thalassemia (TT) minor.
Methods: We determined the MI cutoff value of diagnosing TT minor in children by utilizing a receiver operating characteristic (ROC) curve. Samples with MI values below this threshold, and no detectable gene mutations or IDA were further analyzed using Sanger sequencing or specific primer GAP-PCR.
Genetic screening of α-thalassemia fusion gene using routine flow-through hybridization.
Front Genet
November 2024
Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
Article Synopsis
- The study explores the detection of a rare fusion gene associated with α-thalassemia, which can be mistakenly identified as normal or a different mutation using standard testing methods.
- Over a sample period from January 2019 to January 2024, 32,083 samples were tested, revealing that 25 samples (0.08%) initially appeared suspicious for a common -α deletion but were ultimately found to be negative upon further testing.
- The research concludes that while conventional methods can lead to misdiagnosis, flow-through hybridization is an effective way to screen for the fusion gene, which was identified in a small percentage of the Guangzhou population.
Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease.
Int J Mol Sci
November 2024
Center of Expertise in Hemoglobinopathies and Their Complications, Thalassemia and Sickle Cell Disease Unit, Hippokration General Hospital, 41221 Athens, Greece.
Article Synopsis
- Hemoglobinopathies, such as β-thalassemia and sickle cell disease, are inherited disorders caused by genetic mutations affecting the production and structure of hemoglobin, leading to severe anemia in β-thalassemia and distorted red blood cells in SCD.
- Recent advancements in gene therapy and gene editing show promise, but there is still a need to understand the mechanisms regulating hemoglobin production and to develop new, targeted treatments.
- The review focuses on the complex molecular pathways that impact hemoglobin expression, discusses potential therapeutic strategies, and highlights drugs and interventions designed to restore normal hemoglobin function in affected patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!